Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer
Apply
Mirvetuximab Soravtansine
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step